Back to today’s briefing

Story perspectives

Travelers 60+ Urged to Delay Chikungunya Vaccine

5/13/2025

50 5

Summary

Story summary

Travelers aged 60 and older are urged by the U.S. government to postpone the chikungunya vaccine, Ixchiq, amid concerns over serious neurological side effects. The CDC and FDA are closely examining these troubling reports. Instead, the alternative vaccine, Vimkunya, is advised for those aged 12 and up heading to outbreak regions. Stay safe and informed!

1 of 1

Story summary

Travelers aged 60 and older are urged by the U.S. government to postpone the chikungunya vaccine, Ixchiq, amid concerns over serious neurological side effects. The CDC and FDA are closely examining these troubling reports. Instead, the alternative vaccine, Vimkunya, is advised for those aged 12 and up heading to outbreak regions. Stay safe and informed!